Paul A Gurbel Selected Research

Paul A Gurbel Research Topics

Disease

73	Hemorrhage 05/2024 - 02/2007
67	Acute Coronary Syndrome 05/2024 - 12/2002
55	Thrombosis (Thrombus) 05/2024 - 02/2003
54	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 01/2003
51	Myocardial Infarction 05/2024 - 08/2002
28	Stroke (Strokes) 01/2024 - 01/2006
23	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 04/2005
16	Inflammation (Inflammations) 06/2023 - 01/2006
15	COVID-19 03/2023 - 01/2020
11	Heart Failure 03/2024 - 01/2002
10	Atherosclerosis 01/2021 - 05/2015
8	Peripheral Arterial Disease 11/2020 - 06/2015
7	Ischemic Stroke 12/2023 - 03/2008
7	Ischemia 02/2022 - 01/2006
7	ST Elevation Myocardial Infarction 01/2021 - 01/2012
6	Diabetes Mellitus 03/2024 - 04/2005
6	Thrombophilia 12/2022 - 02/2014
5	Atrial Fibrillation 10/2021 - 07/2011
5	Thromboembolism 01/2018 - 03/2008
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 10/2011
4	Unstable Angina 11/2012 - 12/2002
3	Vascular Diseases (Vascular Disease) 10/2022 - 12/2016
3	Dyspnea (Shortness of Breath) 01/2022 - 07/2010
3	Necrosis 12/2020 - 03/2005
3	Pathologic Constriction (Stenosis) 01/2018 - 04/2016
3	Infarction (Infarctions) 01/2017 - 10/2002
3	Type 2 Diabetes Mellitus (MODY) 12/2016 - 11/2009
3	Transient Ischemic Attack 06/2015 - 08/2012
3	Coronary Disease (Coronary Heart Disease) 01/2013 - 01/2003
2	Heart Arrest (Cardiac Arrest) 11/2023 - 10/2020
2	MINOCA 01/2023 - 12/2022
2	Pneumonia (Pneumonitis) 01/2023 - 04/2015
2	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2018
2	Death (Near-Death Experience) 12/2021 - 04/2005
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021 - 09/2013
2	Hypersensitivity (Allergy) 01/2017 - 09/2011
2	Dyslipidemias (Dyslipidemia) 05/2016 - 07/2015

Drug/Important Bio-Agent (IBA)

88	Clopidogrel (Plavix)FDA Link 12/2023 - 02/2003
70	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 06/2002
20	Prasugrel Hydrochloride FDA Link 12/2023 - 03/2008
19	Adenosine Diphosphate (ADP)IBA 01/2021 - 06/2002
17	TicagrelorIBA 01/2022 - 12/2009
12	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 01/2010
12	omega-Chloroacetophenone (Mace)IBA 03/2024 - 04/2016
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2002
11	AnticoagulantsIBA 10/2021 - 07/2011
11	Thrombin FDA Link 11/2020 - 05/2006
10	FibrinIBA 12/2021 - 05/2006
8	Cytochrome P-450 CYP2C19IBA 11/2023 - 12/2010
7	LipidsIBA 06/2018 - 01/2006
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2015 - 10/2005
5	C-Reactive ProteinIBA 06/2023 - 03/2004
5	vorapaxarIBA 01/2020 - 10/2011
5	Warfarin (Coumadin)FDA LinkGeneric 10/2018 - 07/2011
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2018 - 04/2003
4	Proprotein Convertase 9IBA 01/2023 - 07/2015
4	Platelet Membrane Glycoprotein IIbIBA 08/2022 - 12/2002
4	Glycoproteins (Glycoprotein)IBA 08/2018 - 01/2005
4	Phenobarbital (Luminal)FDA Link 01/2018 - 04/2013
4	thienopyridineIBA 04/2017 - 12/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 03/2004
3	Oxygen (Dioxygen)IBA 11/2023 - 01/2023
3	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2021
3	Metalloproteases (Metalloproteinases)IBA 01/2021 - 01/2008
3	AntibodiesIBA 12/2020 - 07/2015
3	EnzymesIBA 06/2018 - 10/2007
3	oxidized low density lipoproteinIBA 01/2018 - 01/2006
3	bivalirudin (Angiomax)FDA Link 01/2018 - 02/2009
3	Purinergic P2Y Receptor AntagonistsIBA 04/2017 - 03/2010
3	Proton Pump InhibitorsIBA 09/2014 - 01/2010
3	Eptifibatide (Integrilin)FDA Link 02/2009 - 12/2002
2	Fatty Acid-Binding ProteinsIBA 03/2023 - 07/2021
2	sirioIBA 01/2023 - 01/2022
2	Estrogens (Estrogen)FDA Link 12/2022 - 01/2013
2	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2021
2	11-dehydro-thromboxane B2IBA 07/2021 - 01/2020
2	RivaroxabanIBA 01/2020 - 01/2018
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 10/2007
2	Hemoglobins (Hemoglobin)IBA 10/2018 - 06/2016
2	CSL112IBA 05/2018 - 08/2015
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2018 - 08/2015
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018 - 08/2017
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2017 - 05/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2017 - 01/2006
2	TabletsIBA 01/2017 - 09/2014
2	Genetic Markers (Genetic Marker)IBA 04/2016 - 05/2015
2	AntithrombinsIBA 12/2015 - 09/2013
2	P-SelectinIBA 04/2015 - 06/2009
2	Cilostazol (Pletal)FDA LinkGeneric 01/2015 - 11/2012
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2012 - 10/2007
2	Sirolimus (Rapamycin)FDA Link 11/2011 - 12/2006

Therapy/Procedure

107	Therapeutics 05/2024 - 06/2002
53	Percutaneous Coronary Intervention 05/2024 - 01/2006
37	Stents 05/2024 - 10/2002
10	Secondary Prevention 01/2020 - 08/2012
7	Drug-Eluting Stents 01/2020 - 01/2007
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2018 - 08/2011
3	Drug Therapy (Chemotherapy) 10/2020 - 08/2013
2	Length of Stay 12/2023 - 02/2007
2	Heart-Assist Devices 11/2018 - 11/2017